We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2010 by Hallym University Medical Center.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01211886
First Posted: September 30, 2010
Last Update Posted: October 5, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Hallym University Medical Center
  Purpose
Admission BNP was a useful marker for diagnosing and predicting type IV cardio-renal syndrome type IV in patients with chronic kidney disease admitted to the ICU for acute heart failure in a retrospective study. Therefore, we aim to prospectively investigate the utility of serum BNP in evaluating the treatment adequacy and predicting future cardiac events in patients with type IV CRS.

Condition
Chronic Kidney Disease Acute Heart Failure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Utility of BNP in Patients With Type IV Cardio-renal Syndrome Admitted to the ICU: a Prospective Observational Study

Further study details as provided by Hallym University Medical Center:

Biospecimen Retention:   Samples Without DNA
Serum sample for BNP level

Estimated Enrollment: 83
Study Start Date: September 2010
Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with chronic kidney disease admitted to the ICU for acute heart failure (i.e., type IV cardio-renal syndrome)
Criteria

Inclusion Criteria:

  • Adult patients aged > 18 years, Patients with chronic kidney disease (Serum Cr > 2.0, Documented medical history of chronic kidney disease

Exclusion Criteria:

  • Cardiopulmonary resuscitation, Do-not-resuscitate state, Acute kidney injury, ICU stay < 1 day
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Hallym University Medical Center
ClinicalTrials.gov Identifier: NCT01211886     History of Changes
Other Study ID Numbers: f2000tj1
First Submitted: September 29, 2010
First Posted: September 30, 2010
Last Update Posted: October 5, 2011
Last Verified: September 2010

Keywords provided by Hallym University Medical Center:
Brain natriuretic peptide
Cardio-renal syndrome

Additional relevant MeSH terms:
Heart Failure
Kidney Diseases
Renal Insufficiency, Chronic
Cardio-Renal Syndrome
Heart Diseases
Cardiovascular Diseases
Urologic Diseases
Renal Insufficiency
Natriuretic Peptide, Brain
Natriuretic Agents
Physiological Effects of Drugs